2019. HIGH-DOSE-RATE AND LOW-DOSE-RATE BRACHYTHERAPY AS MONOTHERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER. Voprosy onkologii. 65, 3 (Mar. 2019), 434–440. DOI:https://doi.org/10.37469/0507-3758-2019-65-3-434-440.